Related Experiment Videos
Synthetic immunostimulants (excluding sulfur-containing compounds).
Comparative Immunology, Microbiology and Infectious Diseases
|January 1, 1986
Summary
This review explores 15 years of immunostimulating drug design, covering natural product fractionation, chemical modification, and de novo synthesis strategies for novel immunomodulators.
Area of Science:
- Immunopharmacology
- Medicinal Chemistry
- Drug Design
Background:
- Over 15 years, diverse strategies have been employed to develop immunostimulating drugs.
- Approaches include natural product isolation, chemical modification, and de novo synthesis.
Purpose of the Study:
- To review chemical structures and biological profiles of immunostimulants.
- To discuss cellular targets and mechanisms of action for key drug classes.
Main Methods:
- Review of literature on immunostimulant drug design.
- Analysis of chemical structures and immunopharmacological data.
- Categorization of immunostimulants based on design approach.
Main Results:
- Examples of immunostimulants derived from natural products (e.g., thymic hormones, muramyldipeptide [MDP]).
- Modified natural products (e.g., murabutide, lipophilic MDP derivatives, lipopeptides, tuftsin analogs).
- Synthesized molecules screened for immunopharmacological activity.
Conclusions:
- Diverse chemical strategies yield potent immunostimulating agents.
- Understanding structure-activity relationships guides rational drug design.
- Further research into cellular targets and mechanisms is crucial for optimizing immunomodulatory therapies.